LH
Labcorp Holdings Inc.
$312.15
-2.05
(-0.65%)
Mkt Cap
25.60B
Volume
607,853
52W Range
244.52-341.8
Sector
Healthcare
Beta
0.85
EPS (TTM)
12.17 USD
P/E Ratio
25.65
Revenue (TTM)
14.35B USD
Rev Growth (5Y)
-0.0%
EPS Growth (5Y)
-8.0%
AlphaVal · Fair Value
What we estimate one share is worth
$156.90
Overvalued
strong signal
98.9% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C
Stable Earnings Power
53.8 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.
Company Description
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.95B | 13.01B | 12.16B | 11.86B | 13.14B | 13.98B | 11.55B | 11.33B | 10.44B | 9.64B | 8.68B | 6.01B |
| Net Income | 876.50M | 746.00M | 418.00M | 1.28B | 2.38B | 1.56B | 823.80M | 883.70M | 1.27B | 732.10M | 436.90M | 511.20M |
| EPS | 10.54 | 8.89 | 4.80 | 14.04 | 24.58 | 15.99 | 8.41 | 8.71 | 12.39 | 7.14 | 4.42 | 6.03 |
| Free Cash Flow | 1.21B | 1.10B | 874.10M | 1.47B | 2.65B | 1.75B | 1.04B | 925.60M | 1.14B | 897.00M | 726.60M | 535.50M |
| FCF / Share | 14.50 | 13.06 | 10.04 | 16.18 | 27.40 | 18.02 | 10.67 | 9.13 | 11.17 | 8.75 | 7.35 | 6.31 |
| Operating CF | 1.64B | 1.59B | 1.33B | 1.96B | 3.11B | 2.14B | 1.44B | 1.31B | 1.46B | 1.18B | 982.40M | 739.00M |
| Total Assets | 18.39B | 18.38B | 16.73B | 20.16B | 20.39B | 20.07B | 18.02B | 16.19B | 16.57B | 14.25B | 14.29B | 7.30B |
| Total Debt | 7.20B | 7.27B | 5.95B | 6.25B | 6.34B | 6.76B | 7.11B | 6.06B | 6.76B | 5.85B | 6.36B | 3.03B |
| Cash & Equiv | 532.30M | 1.52B | 536.80M | 320.60M | 1.47B | 1.32B | 337.50M | 426.80M | 316.60M | 433.60M | 716.40M | 580.00M |
| Book Value | 8.62B | 8.05B | 7.88B | 10.10B | 10.27B | 9.44B | 7.57B | 6.97B | 6.80B | 5.51B | 4.95B | 2.82B |
| Return on Equity | 0.10 | 0.09 | 0.05 | 0.13 | 0.23 | 0.16 | 0.11 | 0.13 | 0.19 | 0.13 | 0.09 | 0.18 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.73B | 3.54B | 3.52B | 3.56B | 3.53B | 3.35B | 3.33B | 3.28B | 3.22B | 3.18B | 3.03B | 3.06B |
| Net Income | 298.70M | 277.80M | 164.70M | 261.10M | 237.90M | 212.80M | 143.40M | 169.30M | 205.30M | 228.00M | (167.10M) | 183.30M |
| EPS | 3.66 | 3.37 | 2.00 | 3.14 | 2.86 | 2.54 | 1.72 | 2.02 | 2.44 | 2.71 | -1.97 | 2.12 |
| Free Cash Flow | 313.90M | 70.50M | 490.30M | 280.50M | 542.70M | (107.50M) | 665.10M | 161.50M | 432.90M | (163.60M) | 412.40M | 170.60M |
| FCF / Share | 3.84 | 0.86 | 5.94 | 3.38 | 6.50 | -1.29 | 7.96 | 1.92 | 5.15 | -1.95 | 4.86 | 1.97 |
| Operating CF | 445.50M | 191.50M | 614.20M | 387.20M | 620.60M | 18.50M | 777.20M | 277.30M | 561.10M | (29.80M) | 579.60M | 275.50M |
| Total Assets | 18.53B | 19.09B | 18.39B | 18.26B | 18.06B | 17.60B | 18.38B | 18.61B | 16.71B | 16.53B | 16.73B | 16.89B |
| Total Debt | 6.77B | 7.24B | 7.21B | 7.22B | 6.55B | 6.52B | 7.27B | 7.72B | 5.98B | 5.97B | 5.95B | 6.33B |
| Cash & Equiv | 141.80M | 981.10M | 532.30M | 598.10M | 647.30M | 369.40M | 1.52B | 1.52B | 265.10M | 99.30M | 536.80M | 727.90M |
| Book Value | 8.61B | 8.73B | 8.62B | 8.70B | 8.47B | 8.31B | 8.05B | 8.17B | 8.01B | 7.96B | 7.88B | 7.87B |
| Return on Equity | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | -0.02 | 0.02 |
LH News
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Labcorp (NYSE:LH) Shares Gap Down – Should You Sell?
Critical Survey: HCA Healthcare (NYSE:HCA) and Labcorp (NYSE:LH)
Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy
Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts
Why Labcorp Holdings Stock Dropped Today
Labcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript